NuGen Medical Devices Inc.
NGMD.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 3.48% | -5.73% | -44.33% | -62.01% | -8.49% |
| Total Depreciation and Amortization | -12.69% | -9.11% | -1.65% | 2.36% | 12.52% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -5.70% | -44.07% | -23.68% | 18.08% | -43.17% |
| Change in Net Operating Assets | 1,149.34% | 225.13% | 453.64% | -214.60% | 88.89% |
| Cash from Operations | 45.02% | 38.34% | -73.28% | -197.07% | -14.00% |
| Capital Expenditure | -- | -175.00% | -175.00% | -175.00% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.61% | -- | -- | -- | -- |
| Cash from Investing | -7.51% | -9,537.50% | -9,500.00% | -9,462.50% | -6,316.67% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 98.05% | 94.83% | -642.75% | -938.38% | -791.31% |
| Issuance of Common Stock | -89.20% | -70.29% | 106.57% | 1,085.05% | 68.15% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Financing | 50.05% | -66.67% | 85.65% | 1,254.89% | 44.68% |
| Foreign Exchange rate Adjustments | -- | 148.56% | -23.33% | -100.00% | 100.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 413.86% | -190.89% | 76.25% | 120.26% | 21,374.51% |